Related Experiment Video
Updated: Dec 19, 2025

A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
Case report: Neoadjuvant systemic therapy for melanoma
Natiya Gabuniya1, Ankur Khajuria1,2, Jenny L C Geh1
1Guy's and St Thomas NHS Foundation Trust, United Kingdom.
Abstract:
We report a case of rapidly enlarging metastatic melanoma in 45-year-old White male following primary resection of thin melanoma five years ago. Location and large size of the lesion possessed significant risk of complications from surgery, therefore provided a challenge in treatment options. Neoadjuvant targeted chemotherapy was commenced and resulted in a significant reduction in size of the lesion, which allowed subsequent safe surgical resection with no residual disease on histopathology results. This case provides a good example of successful utilization of neoadjuvant systemic therapy in advanced metastatic melanoma.

